New poll finds overwhelming public support for FSA CBD regulation
A new YouGov poll commissioned by The Association for the Cannabinoid Industry (The ACI) demonstrates overwhelming support for recent FSA guidance concerning CBD and...
How medical cannabis can help fight against the US opioid crisis
Abuse of opioids is a real crisis and the US Government have worked hard to solve this issue, but it has endured over the...
Cryo Cure: Perfecting the cannabis drying and curing process
Cryo Cure CEO Tracee McAfee showcases the benefits of freeze drying in cannabis production.
For decades, freeze drying has been a long discussed, but never...
AGT Hybrid Greenhouses: creating climate smart agriculture
Terry Van Gelder, Chief Executive of AGT Technologies, LLC, showcases AGT’s innovative Hybrid Greenhouse.
Terry Van Gelder, Chief Executive of AGT Technologies, LLC, has 20...
New UK fractional cannabis investment platform launched
A new cannabis investment fund app has been launched to provide exposure to businesses focussing on medical cannabis.
Wombat Invest, the mobile-only thematic micro-investing app,...
NHS urged to listen to new guidance on prescribing medical cannabis
The NHS and UK Government are being urged to consider the new, expert guidance for prescribing medical cannabis put forward by the Medical Cannabis...
Revolutionising cannabis cultivation with world-first SNP chip
The word’s-first SNP chip has been developed to help breeders with cultivation by improving the consistency of chemical profiling and disease resistant characteristics of...
Davik: carrying innovation into the cannabis industry
Davik is harnessing years of expertise and innovation to provide dynamic solutions for cannabis crops.
Davik was founded in 1982 in Kibbutz Sde Boker in...
Symtomax: what’s the next step for medical cannabis innovation?
Paul Segal, chairman and co-founder of Symtomax, showcases Symtomax’s contribution to innovations in the medical cannabis sector.
2020 is looking to be a remarkable year...
Calls for CBD regulation following inaccurate CBD levels on products
The Digital Citizens Alliance is calling on Congress for CBD regulation as new research has highlighted the inaccuracy of CBD potency levels listed on...
New research examines the impact of CBD on creative flow
A new study is being conducted that looks at the impact of CBD on creative ‘flow’.
The Flow Research Collective and Ojai Energetics have joined...
THC Global: a truly global multi-market cannabis company
THC Global is delivering quality, scale and price leadership internationally in established and new markets.
THC Global Group Limited is a diversified global cannabis company...
MEDCAN: patient support and advocacy in Switzerland
Franziska Quadri, President of the Medical Cannabis Association Switzerland (MEDCAN), tells MCN about MEDCAN’s advocacy work and the need for legislative change.
Switzerland’s Medical Cannabis...
Malta Enterprise announces first Malta Medical Cannabis Symposium
Malta Enterprise has announced the launch of the first Malta Medical Cannabis Symposium.
In November 2019, Malta Enterprise signed a Memorandum of Understanding with the...
How is the medical cannabis market disrupting the US healthcare industry?
In this article Global Market Insights discusses the impact of the medical cannabis market on the US healthcare industry.
Since the introduction of medical cannabis...
Dana Rohrabacher on evolving cannabis policy in America
Former Republican politician, Dana Rohrabacher, has been a long-time advocate of medical cannabis in America. Here, Medical Cannabis Networks discusses evolving cannabis policy in...
EU CBD archetypes: New Frontiers latest CBD market report
Europe’s hemp-derived CBD market is currently the second-largest CBD market after the U.S. – but what do you know about customer behaviour and consumption?
Despite...
The Cannabis Investor Summit: demonstrating the power of collaboration
NNE, collaborating with Invest in Denmark and Invest in Odense, hosted the Cannabis Investor Summit, here MCN shine a light on the strength of...
Study shows that pharmaceutical CBD is best for reducing seizures
A new study has shown that ‘not all medical cannabis is the same’ by demonstrating how artisanal CBD is not as effective as pharmaceutical...
New CBD and CBG ‘micropearl’ helps with controlled cannabis dosing
A new CBD and CBG solid ‘micropearl’ cannabis concentrate product, aimed at helping patients and consumers with controlled cannabis dosing, has received a patent...
